Abstract
Editor—We thank Dr Cullen for his positive comments for our article.1 We agree with his excellent points on the contribution of erythrocytes to haemostasis, and also on the recommendation to monitor and maintain appropriate haemoglobin levels in PPH patients. Many haematological and physiological factors influence the coagulation system, directly or indirectly, and it is crucial to understand whether these factors should impact clinical management of haemostasis during PPH.

This publication has 11 references indexed in Scilit: